Skip to content

Measuring glucose and lactate in healthy volunteers and patients with diabetes: Do new blood collection tubes produce more accurate laboratory values?

When measuring laboratory plasma glucose in healthy and diabetic participants, are citrate/fluoride blood collection tubes superior to fluoride tubes with regards to minimising pre-analytical loss of glucose?

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12615000004561
Enrollment
50
Registered
2015-01-07
Start date
2015-01-22
Completion date
2015-08-24
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Accurate estimation of laboratory plasma glucose is important for the screening, diagnosis and management of several conditions, including diabetes. One of the reasons why laboratory plasma glucose results may not be accurate relates to in vitro glycolysis i.e. glucose is lost due to red cell uptake of glucose, if red cells are not separated immediately from plasma, following venesection. Routinely available blood collection tubes are not good glycolysis inhibitors. A 'new' citrate/fluoride blood collecting system, manufactured by Terumo, is thought to be much better at inhibiting glycolysis. Published information is however limited and there is virtually no information available from study participants with hyperglycaemia. The current study aims to compare pre-analytical glucose loss using the 'new' collection system with the systems already in routine use. The study also aims to compare intra-individual rates of glycolysis. If rates of glycolysis are similar both between and also within participants, then it may be possible to apply a correction factor when undertaking comparisons of serial glucose values across 'old' and 'new' collection systems.

Interventions

Collection of 40ml venous blood from the antecubital fossa of participants, on two separate occasions up to one week apart. Pre-analytical loss of glucose will be determined on both occasions, using three different blood collection tube systems. (One is the 'new' citrate/fluoride collection tube, the other two collection tubes are in common everyday use, that is they are used in routine clinical care).

Sponsors

Dr Helen Lunt
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Diagnosis
Masking
Blinded (masking used) (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Participants are either healthy volunteers (N=20) or subjects with diabetes attending the local diabetes clinic (N=20)

Exclusion criteria

Previous history of 'difficult' venesection

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026